Is a complete TSXV/IBO research report available?

No complete published report is available for tsxv/IBO (TSXV/IBO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

TSXV/IBO (TSXV/IBO)

TSX Venture Exchange: TSXV/IBO · CAD

CA$0.01

-0.01 (-50.0%)· Recorded snapshot

Market cap	1.6M
Revenue (ttm)	2.1M
Net income (ttm)	-1.5M
EPS (ttm)	-CA$0.01
Shares out	312.9M
Volume	1,660,150
Beta	4.31

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.1M
Net income (ttm): -1.5M
EPS (ttm): -CA$0.01
Market cap: 1.6M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All TSXV/IBO indicators

Market & fundamental data

Available fields

154

Groups with data

Currency

CAD

Showing 154 of 154 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 4M
Exchange	TSX Venture Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Biotechnology
Isin	CA91360F1099
Last refreshed	2026-09-07
Market cap	CAD 1.6M
Price	CAD 0.01
Price currency	CAD
Sector	Healthcare
Sic	8063
Symbol	tsxv/IBO
Website	https://universalibogaine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-94.38%
EV/Sales	1.95x
FCF yield	-42.42%
P/B ratio	5.75x
P/S ratio	0.76x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-34.25%
EBITDA Margin	-17.39%
Gross margin	17.31%
Gross Profit	CAD 356,649
Gross Profit Growth	-45.95%
Gross Profit Growth Q	191.01%
Gross Profit Growth3 Y	-12.96%
Net Income	CAD -1.5M
Net Income Growth Quarters	5%
Pretax Margin	-71.66%
Profit Margin	-71.66%
ROA	-9.46
Roa5y	-61
ROCE	-35.38
ROE	-161.4
Roe5y	-298.3
ROIC	-12.3

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-75.02%
Cagr3y	-37%
EPS Growth Quarters	5
Revenue Growth	-11.68x
Revenue Growth Q	30.61x
Revenue Growth Qo Q	88.62x
Revenue Growth3 Y	29.92x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 0.44
Assets	CAD 4M
Cash	CAD 127,746
Current Assets	CAD 783,819
Current Liabilities	CAD 2M
Debt	CAD 2.6M
Debt Equity	CAD 9.45
Debt FCF	CAD -3.88
Equity	CAD 272,174
Interest Coverage	-4.6
Liabilities	CAD 3.7M
Long Term Assets	CAD 3.2M
Long Term Liabilities	CAD 1.7M
Net Cash	CAD -2.4M
Net Cash By Market Cap	CAD -156
Net Debt Equity	CAD 8.98
Tangible Book Value	CAD 272,174
Tangible Book Value Per Share	CAD 0
WACC	13.5

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.39
Net Working Capital	CAD -507,013
Quick ratio	0.37
Working Capital	CAD -1.2M
Working Capital Turnover	CAD -2.54

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-38.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-75%
200-day SMA	0.02
3Y total return	-75%
50-day SMA	0.01
50-day SMA vs 200-day SMA	50under200
All Time High	0.25
All Time High Change	-98%
All Time High Date	2021-11-03
All Time Low	0.01
All Time Low Change	0%
All Time Low Date	2023-09-20
ATR	0
Beta	4.31
Beta1y	-0.32
Beta2y	-1.16
High	0.01
High52	0.05
High52 Date	2025-07-02
High52ch	-88.89%
Low	0.01
Low52	0.01
Low52 Date	2026-02-02
Low52ch	0%
Ma50ch	-34.21%
Price vs 200-day SMA	-70.76%
RSI	42.68
RSI Monthly	38.84
RSI Weekly	40.48
Sharpe ratio	2.08x
Sharpe Ratio3y	1.5x
Sortino ratio	4.36
Sortino Ratio3y	2.96
Total Return	-38.51%
Tr1w	-50%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Net Borrowing	-218,473
Shares Insiders	1.77%
Shares Out	312,858,516
Shares Qo Q	0%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD -730,571
Adjusted OCF	-709,876
Average Volume	241,304.4x
Bv Per Share	0
CAPEX	CAD -20,695
Ch1w	-50
Ch1y	-75
Ch3y	-75
Ch6m	-80
Change	-50%
Change From Open	0
Close	0.01
Days Gap	0
Depreciation Amortization	347,451
Dollar Volume	8,300.8
Earnings Date	2027-01-26
EBIT	CAD -705,732
EBITDA	CAD -358,281
EPS	CAD -0.01
F Score	3
FCF	CAD -663,497
FCF EV Yield	-16.55x
FCF Per Share	CAD -0
Financing CF	321,129
Fiscal Year End	July
Investing CF	-20,695
Is Primary Listing	1
Last Earnings Date	2025-11-28
Last Report Date	2025-04-30
Ma150	0.02
Ma150ch	-67.74%
Ma20	0.01
Ma20ch	-35.9%
Net CF	-342,368
Next Earnings Date	2027-01-26
Open	0.01
Ppne	3,222,869
Price Date	2026-02-02
Ptbv Ratio	5.75
Relative Volume	6.88x
Revenue	2,060,280x
SBC By Revenue	3.26x
Share Based Comp	67,074
Tr6m	-80%
Volume	1,660,150
Z Score	-9.42

TSXV/IBO (TSXV/IBO)

Price

Financial snapshot

Fair-value bridge

Latest news · TSXV/IBO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All TSXV/IBO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on TSXV/IBO

Frequently asked questions